Modifiable Lifestyle and Environmental Determinants of Ovarian Cancer Risk: Implications for Primary Prevention
Ovarian cancer (OC) remains the most lethal gynecologic malignancy worldwide, largely due to late-stage diagnosis and the absence of effective screening strategies. As a result, primary prevention is a critical approach to reducing disease burden. This narrative review summarizes current evidence on modifiable lifestyle, reproductive, and environmental factors associated with OC risk, based on a comprehensive PubMed, MEDLINE, Scopus, and Web of Science search conducted through April 2026. Consistent protective associations have been reported for reproductive factors, including parity, breastfeeding, oral contraceptive use, salpingectomy, and tubal ligation. Among lifestyle factors, excess body weight is modestly associated with increased OC risk, while evidence regarding physical activity remains inconclusive. Diets rich in fiber and aligned with a Mediterranean pattern appear protective, potentially through hormonal modulation and anti-inflammatory effects. In contrast, pro-inflammatory diets high in trans fats and refined carbohydrates may increase risk, whereas omega-3 fatty acids show potential protective benefits. Chronic pelvic inflammation, particularly related to Chlamydia trachomatis infection, has been linked to elevated epithelial OC risk. Smoking demonstrates a dose–response association with mucinous tumors. Environmental exposures, including genital talc use and endocrine-disrupting chemicals such as phthalates and bisphenols, have linked to a possible, albeit modest, increase in risk, although the causal mechanisms remain uncertain. Although individual associations are generally modest, their cumulative population impact may be substantial. Integrating lifestyle-based prevention strategies into gynecologic practice and public health initiatives could represent a cost-effective approach to reducing OC incidence and improving women’s health outcomes.
Authors
- Doriana Armenise
- Vito Andrea Capozzi (ORCID: https://orcid.org/0000-0003-4720-5663)
- Roberto Berretta (ORCID: https://orcid.org/0000-0003-2324-5409)
- Martina Arcieri (ORCID: https://orcid.org/0000-0002-8257-0618)
- S Filippin (ORCID: https://orcid.org/0009-0001-0933-0503)
- Filippo Bordin
- Federica Perelli (ORCID: https://orcid.org/0000-0002-5508-0875)
- Guglielmo Stabile (ORCID: https://orcid.org/0000-0001-9266-3896)
- Lino Del Pup
- Sara Pregnolato (ORCID: https://orcid.org/0000-0003-1540-1897)
- Stefano Cianci (ORCID: https://orcid.org/0000-0002-0548-9891)
- Federico Paparcura (ORCID: https://orcid.org/0009-0007-0881-7233)
- Nicoletta Crivellaro
- Fedro Alessandro Peccatori
- The Italian Women’s Ovarian Health and Prevention Collaborative Group
- Stefano Restaino (ORCID: https://orcid.org/0000-0002-7848-0329)
- Giorgio Bogani
- Giuseppe Vizzielli (ORCID: https://orcid.org/0000-0002-2424-2691)
- Lorenza Driul
- Carlo Ronsini (ORCID: https://orcid.org/0000-0002-9023-282X)
Institutions
- University of Foggia (IT)
- University of Messina (IT)
- University of Parma (IT)
- University of Udine (IT)
- University of Sassari (IT)
- Meyer Children's Hospital (IT)
- Ospedale Santa Maria della Misericordia di Udine (IT)
- Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Azienda Usl Toscana Centro (IT)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- European Institute of Oncology (IT)
Publication Details
- Journal
- Healthcare
- Published
- 2026-05-01
- DOI
- https://doi.org/10.3390/healthcare14091215
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00